Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-26T05:11:23.631Z Has data issue: false hasContentIssue false

P-992 - Smoking During Pregnancy and Postnatal Period and Postpartum Depression

Published online by Cambridge University Press:  15 April 2020

M.L. Imaz
Affiliation:
Perinatal Psychiatry and Gender Research Program, Department of Psychiatry, Hospital Clínic Barcelona, Spain
E. Gelabert
Affiliation:
Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, Spain
L. Garcia Esteve
Affiliation:
Clinical and Health Psychology, Universitat Autònoma de Barcelona, Bellaterra, Spain
J. Sanjuan
Affiliation:
Psychiatry, Universidad de Valencia. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Valencia, Spain
K. Langhor
Affiliation:
Human Pharmacology and Clinical Neurosciences, IMIM-Hospital del Mar, Barcelona, Spain Department of Psychiatry, Hospital Clinic Barcelona, Barcelona, Spain
E. Vilella
Affiliation:
University Psychiatric Hospital Institut Pere Mata, IISPV, University Rovira i Virgili, Reus, Spain
M. Torrens
Affiliation:
Psychiatry, Parc de Salut Mar, Barcelona, Spain
R. Martin-Santos
Affiliation:
Substance Use Disorders Research Group, IMIM-Hospital del Mar, Barcelona, Spain Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Substance use in pregnancy is an increasingly common problem and has become an important public health issue. Postpartum depression has a high prevalence (10%) of women in Spanish population.

Objetive/aim

To study the impact of perinatal tobacco use in postpartum depression.

Methods

A cohort study of 1804 puerperal Spanish Caucasian women of general population. Variables collected: socio-demographic, obstetric, personal and family psychiatric history, substance use during pregnancy and 6 months postpartum, depressive symptoms (EPDS) and anxiety traits (STAI) at 2–3 days, 8 weeks and 32 weeks postpartum. Major postpartum depression (MPD) (EPDS>9) were confirmed through a structured interview (DIGS-DSM-IV). The sample was divided in four groups:

  1. 1) No smoking,

  2. 2) Smoking postpartum,

  3. 3) Smoking pregnancy,

  4. 4) Smoking pregnancy & postpartum.

Results

The mean (SD) age was 31.8 (4.6), 46% were primiparous, 96.5% were married and 68% had at least secondary school. Thirty-one per cent had family and 17% personal psychiatric history. Twenty one percent reported tobacco use during pregnancy and 28.2% use tobacco in postpartum. Tobacco use in the four groups and MPD at 8 weeks (x2 = 17.872;df = 3;p < 0.001) and at 32 weeks postpartum (x2 = 15.582;df = 3;p = 0.001) were different. Only smoking postpartum group had a risk four times higher of having MPD at 8 weeks postpartum (OR=4.3; 95%CI = 1.91–9.66). Others independent variables: personal psychiatry history (OR = 2.53; 95%CI = 1.55–4.22), family psychiatry history (OR = 1.87; 95%CI = 1.15–3.06) and anxiety traits (OR = 1.12, 95%CI = 1.08–1.16). The results at 32 weeks showed the same risk factors.

Conclusions

The use of tobacco in postpartum had a considerable impact on mother's psychiatric health.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.